Health
'No evidence' NYC coronavirus variant impacts vaccines, causes severe illness: official
New York City health officials on Thursday said there is no evidence showing the newly reported variant, B.1.526, is driving trajectory of infections, reduces vaccine efficacy or results in more severe illness.
Inside the ER in Laval, Que., one of the worst hit cities in Canada
News/Canada/Montreal: For the first time since the start of the pandemic, Laval's Cité-de-la-Santé hospital gave CBC News exclusive access inside the ER to see how it works and the precautions it has put in place to keep everyone safe.
California halts shared COVID-19 vaccine codes system after misuse
California is revamping its plan to help essential workers and seniors in underserved communities get coronavirus vaccinations after officials learned that appointment access codes were leaked to people who were not eligible for the shots.
Pfizer COVID-19 vaccine 94% effective in real-world conditions: study
A coronavirus vaccine developed by Pfizer and BioNTech showed to drop symptomatic COVID-19 by 94%, per new research out of Israel. The peer-reviewed results offer a first look at effectiveness in real-world conditions, and showed consistency with high 95% vaccine efficacy reported during clinical trials.
Coronavirus: What's happening in Canada and around the world on Thursday
News/World: The director of the Africa Centers for Disease Control and Prevention is warning it would be a "fatal mistake" if the developed world takes the attitude of "we'll vaccinate our people, and people in other parts of the world can take care of their own."
Moderna begins studying potential COVID-19 vaccine booster targetting variant first detected in South Africa
News/Health: Drug manufacturer Moderna says it will begin testing a variant-specific version of its COVID-19 vaccine that would target the B1351 variant first detected in South Africa.
Saskatoon mother believes son died participating in online challenge
News/Canada/Saskatoon: Cash Anderson was a vivacious 13-year-old boy. His mom, Melanie, said he would wake up early all the time to get outside and skateboard, and he always had to make sure his fiery red curls were sitting just right before school.
Moderna’s new COVID-19 vaccine for South African variant ready for human testing, company says
Moderna on Wednesday announced that the COVID-19 vaccine it recently developed to address a concerning new coronavirus variant first identified in South Africa is ready to be tested in people in clinical trials.